Original scientific paper
Incidence and Prognosis of COVID-19 in Patients with Psoriasis: A Multicenter Prospective Study from the Eastern Black Sea Region of Turkey
Leyla Baykal Selcuk
orcid.org/0000-0001-7956-4033
; Karadeniz Techinical University School of Medicine, Department of Dermatology and Venerology, Trabzon, Turkey
Burak Aksan
; Giresun University School of Medicine, Department of Dermatology and Venerology, Giresun, Turkey
Sevgi Kulakli
; Giresun University School of Medicine, Department of Dermatology and Venerology, Giresun, Turkey
Isıl Deniz Oguz
; Giresun University School of Medicine, Department of Dermatology and Venerology, Giresun, Turkey
Mustafa Gündogdu
; Ordu State Hospital, Department of Dermatology and Venerology, Ordu, Turkey
Göktürk Dere
; Ordu State Hospital, Department of Dermatology and Venerology, Ordu, Turkey
Sevda Onder
; Ordu University School of Medicine, Department of Dermatology and Venerology, Ordu, Turkey
Fatma Etgu
; Ordu University School of Medicine, Department of Dermatology and Venerology, Ordu, Turkey
Deniz Aksu Arica
; Karadeniz Techinical University School of Medicine, Department of Dermatology and Venerology, Trabzon, Turkey
Seyda Ece Oguzer
; Karadeniz Techinical University School of Medicine, Department of Dermatology and Venerology, Trabzon, Turkey
Burcu Aydemir
; Karadeniz Techinical University School of Medicine, Department of Dermatology and Venerology, Trabzon, Turkey
İbrahim Etem Arıca
; Rize Recep Tayyip Erdo- gan University School of Medicine, Department of Dermatology and Venerology, Rize, Turkey
Yunus Saral
; Rize Recep Tayyip Erdo- gan University School of Medicine, Department of Dermatology and Venerology, Rize, Turkey
Savaş Yayli
; Karadeniz Techinical University School of Medicine, Department of Dermatology and Venerology, Trabzon, Turkey
Abstract
COVID-19 infection can have a poor prognosis, especial-
ly in patients with chronic diseases and those receiving immunosup-
pressive or immunomodulating therapies.
This study aimed to investigate the severity of COVID-19 infection
in patients with psoriasis and compare the infection severity for sys-
temic treatments and comorbidities.
We conducted a study in the dermatology clinics of five different
centers in the Eastern Black Sea region of Turkey. Four hundred and
eighty-eight patients were included, and 22.5% were confirmed as
having COVID-19 infection.
In our study, the frequency of hospitalization rates due to COVID-19
infection were similar (15.4%, 25.9% respectively) in patients receiv-
ing biological treatment and receiving non-biological systemic treat-
ment (P=0.344). Hospitalization rates were higher in patients with
hypertension, androgenetic alopecia, and acitretin use (P=0.043,
P=0.028, P=0.040).
In conclusion, current biologic treatments and non-biologic system-
ic treatments in patients with psoriasis did not appear to increase the
risk of the severe form of COVID-19, except for acitretin.
Keywords
COVID-19; psoriasis; comorbidity; biologic; non-bio- logic systemic drugs
Hrčak ID:
299664
URI
Publication date:
14.12.2022.
Visits: 318 *